Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Feb;28(2):431-438.
doi: 10.1681/ASN.2016090951. Epub 2017 Jan 3.

Hereditary Lysozyme Amyloidosis Variant p.Leu102Ser Associates with Unique Phenotype

Affiliations
Case Reports

Hereditary Lysozyme Amyloidosis Variant p.Leu102Ser Associates with Unique Phenotype

Samih H Nasr et al. J Am Soc Nephrol. 2017 Feb.

Abstract

Lysozyme amyloidosis (ALys) is a rare form of hereditary amyloidosis that typically manifests with renal impairment, gastrointestinal (GI) symptoms, and sicca syndrome, whereas cardiac involvement is exceedingly rare and neuropathy has not been reported. Here, we describe a 40-year-old man with renal impairment, cardiac and GI symptoms, and peripheral neuropathy. Renal biopsy specimen analysis revealed amyloidosis with extensive involvement of glomeruli, vessels, and medulla. Amyloid was also detected in the GI tract. Echocardiographic and electrocardiographic findings were consistent with cardiac involvement. Proteomic analysis of Congo red-positive renal and GI amyloid deposits detected abundant lysozyme C protein. DNA sequencing of the lysozyme gene in the patient and his mother detected a heterozygous c.305T>C alteration in exon 3, which causes a leucine to serine substitution at codon 102 (Human Genome Variation Society nomenclature: p.Leu102Ser; legacy designation: L84S). We also detected the mutant peptide in the proband's renal and GI amyloid deposits. PolyPhen analysis predicted that the mutation damages the encoded protein. Molecular dynamics simulations suggested that the pathogenesis of ALys p.Leu102Ser is mediated by shifting the position of the central β-hairpin coordinated with an antiparallel motion of the C-terminal helix, which may alter the native-state structural ensemble of the molecule, leading to aggregation-prone intermediates.

Keywords: amyloidosis; hereditary amyloid; lysozyme; malfolding proteins.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Renal and GI biopsy findings. (A) Abundant glomerular mesangial, glomerular capillary wall, and arterial congophilic amyloid deposits are seen. (B) Renal CR-positive amyloid deposits display apple-green birefringence under polarized light. (C) Extensive congophilic amyloid deposits are seen in the medulla involving collecting ducts and vasa recta basement membranes. (D) On electron microscopy, amyloid deposits are composed of randomly oriented straight fibrils. (E) The intestinal mucosal amyloid deposits stain strongly for lysozyme using immunohistochemistry. Paneth cells at the bases of the glands serve as an internal positive control for lysozyme. Proteomic data confirming the diagnosis of ALys with the p.Leu102Ser abnormality from this specimen are presented in Supplemental Figure 1. Magnification, ×100 in A–C and E; ×50,000 in D.
Figure 2.
Figure 2.
Proteomic and genetic detection of amyloidosis derived from lysozyme Leu102Ser variant. (A) Proteins highlighted with yellow stars are the universal amyloid tissue biomarkers. LYZ protein is highlighted with a blue star. Numbers in the boxes represent the total numbers of spectra matched to the protein in a sample. Multiple dissections are presented independently. (B) Portions of the LYZ sequence detected in the sample are highlighted with bold black letters on yellow background. (C) Tandem mass spectrometry spectrum of the mutant peptide detected in the CR-positive renal amyloid deposits of the patient. An arrow marks the p.Leu102Ser amino acid sequence change. (D) LYZ gene mutation in the patient. An arrow marks the detected c.305T→C (p.Leu102Ser) mutation.
Figure 3.
Figure 3.
Family tree of the affected kindred. The proband is indicated in red. Dead individuals are indicated by a diagonal line through the symbol. Miscarriages are indicated with diamonds.
Figure 4.
Figure 4.
MD of ALys p.Leu102Ser. (A) Previously reported ALys coding variants are marked by black spheres. Newly observed p.Leu102Ser variant site is indicated in orange text. Previously reported variants are either within the same sequence-based region of LYZ or closely interact with them in three dimensions. p.Leu102Ser is distant in sequence but close in space to previously reported amyloidosis variants. (B) The root mean squared deviation (RMSD) across replicates and for each variant is shown by a smoothed density plot, where the width of each shape is proportional to the number of observations. The WT is summarized in blue, the novel L102S is in red, and three previously identified amyloidosis variants are in shades of orange. (C) PCs were computed across all 15 simulations. The first PC is visualized on the LYZ structure. The final WT conformation is shown in cartoon representation. Amino acid 102 is marked by a red sphere, whereas 72, 74, and 75 are marked by orange spheres. Two terminal amino acids exhibited large motions and are not shown. The first PC indicated anticorrelated motion between the β-hairpin and C-terminal α-helices. Both known and novel ALys variants destabilize LYZ protein by introducing flexibility in the C terminus of the protein.

References

    1. Dember LM: Amyloidosis-associated kidney disease. J Am Soc Nephrol 17: 3458–3471, 2006 - PubMed
    1. Valleix S, Verona G, Jourde-Chiche N, Nédelec B, Mangione PP, Bridoux F, Mangé A, Dogan A, Goujon JM, Lhomme M, Dauteuille C, Chabert M, Porcari R, Waudby CA, Relini A, Talmud PJ, Kovrov O, Olivecrona G, Stoppini M, Christodoulou J, Hawkins PN, Grateau G, Delpech M, Kontush A, Gillmore JD, Kalopissis AD, Bellotti V: D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile. Nat Commun 7: 10353, 2016 - PMC - PubMed
    1. Nasr SH, Dasari S, Hasadsri L, Theis JD, Vrana JA, Gertz MA, Muppa P, Zimmermann MT, Grogg KL, Dispenzieri A, Sethi S, Highsmith WE Jr., Merlini G, Leung N, Kurtin PJ: Novel type of renal amyloidosis derived from Apolipoprotein-CII [published online ahead of print June 13, 2016]. J Am Soc Nephrol - PMC - PubMed
    1. Pepys MB, Hawkins PN, Booth DR, Vigushin DM, Tennent GA, Soutar AK, Totty N, Nguyen O, Blake CC, Terry CJ, Feest TG, Zalin AM, Hsuan JJ: Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 362: 553–557, 1993 - PubMed
    1. Yazaki M, Farrell SA, Benson MD: A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis. Kidney Int 63: 1652–1657, 2003 - PubMed

Publication types

LinkOut - more resources